Bumper Offer - Urjas oil Just @ Rs. 1
Nasivion Mini Nasal Drops is a prescription medicine that is available as a Drops. Blocked Nose are some of its major therapeutic uses. Nasivion Mini Nasal Drops also has some secondary and off-label uses. These are listed below.
The right dosage of Nasivion Mini Nasal Drops depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Some other side effects of Nasivion Mini Nasal Drops have been listed ahead. Usually, these side effects of Nasivion Mini Nasal Drops go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Nasivion Mini Nasal Drops is Unknown for pregnant women and Unknown for women who are breastfeeding. In addition, Nasivion Mini Nasal Drops's effects on the liver, heart and kidney are discussed below in the Nasivion Mini Nasal Drops related warnings section.
Nasivion Mini Nasal Drops can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Nasivion Mini Nasal Drops in conditions like Glaucoma. The section on Nasivion Mini Nasal Drops contraindications lists all such conditions.
Drug interactions for Nasivion Mini Nasal Drops have been reported in the medical literature. See below for a complete list.
You should also be aware that Nasivion Mini Nasal Drops is safe while driving, and is addiction.
Nasivion Mini Nasal Drops is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Nasivion Mini Nasal Drops is used -
Moderate
Mild
Is the use of Nasivion Mini Nasal Drops safe for pregnant women?
The effects of Nasivion on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Nasivion Mini Nasal Drops safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Nasivion for breastfeeding women are not known.
What is the effect of Nasivion Mini Nasal Drops on the Kidneys?
Nasivion may have mild side effects on the kidneys.
What is the effect of Nasivion Mini Nasal Drops on the Liver?
Nasivion may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Nasivion Mini Nasal Drops on the Heart?
You can take Nasivion without any fear of damage to the heart.
Nasivion Mini Nasal Drops should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Nasivion Mini Nasal Drops unless your doctor advises you to do so -
Is this Nasivion Mini Nasal Drops habit forming or addictive?
Nasivion Mini Nasal Drops is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Nasivion Mini Nasal Drops does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, the use of Nasivion Mini Nasal Drops is considered safe.
Is it able to treat mental disorders?
Nasivion Mini Nasal Drops is unable to treat or cure mental disorders.
Interaction between Food and Nasivion Mini Nasal Drops
Information is not available on the interaction of any foods with Nasivion Mini Nasal Drops, due to a lack of research on this.
Interaction between Alcohol and Nasivion Mini Nasal Drops
No research has been done on this till date. Therefore, it is not known what the effect of taking Nasivion Mini Nasal Drops with alcohol will be.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rhofade™ (oxymetazoline hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Allegra® (fexofenadine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 163,166
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 566
